MAPK3 and non-small cell lung carcinoma: It has been reported that TSAIII downregulates the expression of MMP-2 and MMP-9 and inhibits the migration and invasion of human non-small-cell lung cancer A549 cells by attenuating the ERK1/2, Src/FAK, and β-catenin signaling pathways [74] (Table 1).